Edesa Biotech Inc (EDSA) — Cash Flow-to-Debt Ratio
Edesa Biotech Inc (EDSA) has a Cash Flow-to-Debt Ratio of -0.94x as of March 2026, meaning its operating cash flow of $-2.05 Million could theoretically repay -1% of its total liabilities ($2.19 Million) in one year. Explore Edesa Biotech Inc long-term investment allocation to see how much of total assets are deployed in long-term investments.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Edesa Biotech Inc Cash Flow-to-Debt Ratio (2010–2025)
Historical debt coverage capacity for Edesa Biotech Inc across 16 annual periods. Also explore Edesa Biotech Inc assets under control for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Edesa Biotech Inc (2010–2025)
Year-by-year debt coverage analysis for Edesa Biotech Inc. For market capitalisation and broader financial context, see how much is Edesa Biotech Inc worth.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -6.79x | $-7.32 Million | $1.08 Million | ▼ -154.5% |
| 2024 | -2.67x | $-4.89 Million | $1.83 Million | ▲ +26.0% |
| 2023 | -3.60x | $-6.64 Million | $1.84 Million | ▲ +35.9% |
| 2022 | -5.62x | $-12.28 Million | $2.18 Million | ▲ +37.2% |
| 2021 | -8.95x | $-13.66 Million | $1.53 Million | ▼ -641.7% |
| 2020 | -1.21x | $-4.99 Million | $4.13 Million | ▲ +88.5% |
| 2019 | -10.50x | $-4.85 Million | $461.63K | ▼ -12.2% |
| 2018 | -9.35x | $-4.62 Million | $493.38K | ▲ +36.1% |
| 2017 | -14.64x | $-4.70 Million | $320.95K | ▼ -102.7% |
| 2016 | -7.22x | $-4.51 Million | $623.64K | ▼ -289.8% |
| 2015 | -1.85x | $-4.41 Million | $2.38 Million | ▼ -194.2% |
| 2014 | -0.63x | $-4.27 Million | $6.77 Million | ▼ -151.0% |
| 2013 | -0.25x | $-2.92 Million | $11.65 Million | ▲ +95.6% |
| 2012 | -5.70x | $-3.95 Million | $692.27K | ▲ +65.3% |
| 2011 | -16.44x | $-2.62 Million | $159.14K | ▼ -844.5% |
| 2010 | -1.74x | $-732.23K | $420.61K | — |